Document is current
Any future updates will be listed below
-
Authors
Johnson, Matthew P.
Tariq, Muhammad Hamza
Hughes, Michael Pycraft
Kohli, Nupur
-
Funding
Funding for this research was provided by:
Khalifa University of Science, Technology and Research (FSU-2022-020.)
Khalifa University of Science, Technology and Research (FSU-2022-023 / 8474000443)
- License Information
-
More Information
Article History
Received: 16 July 2025
Accepted: 2 December 2025
First Online: 20 December 2025
Declarations
:
: Under ethical approval of the Abu Dhabi Health Research and Technology Ethics Committee and informed consent of participants (ADHRTC-2022-326, primary umbilical cord mesenchymal stem cells (UCMSCs) from two donors were obtained from discarded umbilical cord biowaste during birth, following standard routine protocols at Abu Dhabi stem cell centre (ADSCC). Additionally, the Research Ethics Committee of Khalifa University of Science and Technology Institute review board approved the study “Regenerative therapies for musculoskeletal disorder” for sample collection (H22-026). Study approved in August 2022.
: The authors declare that they have not use AI-generated work in this manuscript.
: Author MPH is a Director of DEParator Ltd. which manufactures one of the instruments used in this study. MPJ, MHT and NK declare no competing interests.
